scholarly journals Impact of shoulder complaints after neck dissection on shoulder disability and quality of life

2008 ◽  
Vol 139 (1) ◽  
pp. 32-39 ◽  
Author(s):  
Martijn M. Stuiver ◽  
Cornelis P. van Wilgen ◽  
Erlijn M. de Boer ◽  
Cees J. T. de Goede ◽  
Muriel Koolstra ◽  
...  
2010 ◽  
Vol 20 (1) ◽  
pp. 113-122 ◽  
Author(s):  
D.T. LAUCHLAN ◽  
J.A. Mc CAUL ◽  
T. Mc CARRON ◽  
S. PATIL ◽  
J. Mc MANNERS ◽  
...  

Head & Neck ◽  
2018 ◽  
Vol 41 (5) ◽  
pp. 1213-1219 ◽  
Author(s):  
Kyle Wang ◽  
Dominic H. Moon ◽  
Robert J. Amdur ◽  
Roi Dagan ◽  
Nathan C. Sheets ◽  
...  

2008 ◽  
Vol 139 (4) ◽  
pp. 511-518 ◽  
Author(s):  
Amy Anne Donatelli-Lassig ◽  
Sonia A. Duffy ◽  
Karen E. Fowler ◽  
David L. Ronis ◽  
Douglas B. Chepeha ◽  
...  

Objective To determine differences in quality of life (QOL) between patients with head and neck cancer who receive chemoradiation versus chemoradiation and neck dissection. Methods A prospective cohort study was conducted at two tertiary otolaryngology clinics and a Veterans Administration hospital. Sample: 103 oropharyngeal patients with Stage IV squamous cell carcinoma treated via chemoradiation ± neck dissection. Intervention: self-administered health survey to collect health, demographic, and QOL information pretreatment and 1 year later. Main outcome measures: QOL via SF-36 and HNQoL. Descriptive statistics were calculated for health/clinical characteristics, demographics, and QOL scores. t tests evaluated changes in QOL over time. Results Sixty-five patients underwent chemoradiation and 38 patients underwent chemoradiation and neck dissection. Only the pain index of the SF-36 showed a significant difference between groups ( P < 0.05) with the neck dissection group reporting greater pain. Conclusions After post-treatment neck dissection, patients experience statistically significant decrement in bodily pain domain scores, but other QOL scores are similar to those of patients who underwent chemoradiation alone.


2017 ◽  
Vol 274 (12) ◽  
pp. 4183-4193
Author(s):  
Elise M. Gane ◽  
Steven M. McPhail ◽  
Anna L. Hatton ◽  
Benedict J. Panizza ◽  
Shaun P. O’Leary

2004 ◽  
Vol 130 (2) ◽  
pp. 149 ◽  
Author(s):  
Sean Laverick ◽  
Derek Lowe ◽  
James S. Brown ◽  
E. David Vaughan ◽  
Simon N. Rogers

2000 ◽  
Vol 110 (4) ◽  
pp. 620-626 ◽  
Author(s):  
Jeffrey E. Terrell ◽  
Deborah E. Welsh ◽  
Carol R. Bradford ◽  
Douglas B. Chepeha ◽  
Ramon M. Esclamado ◽  
...  

2019 ◽  
Author(s):  
Lei Wang ◽  
Liang Wang ◽  
Xuefei Song ◽  
Chang Cui ◽  
Chunyue Ma ◽  
...  

Abstract Background: There is growing discussion of the relationship between health¬–related quality of life (HRQoL) and patient survival, which has been going on for the last few decades. Clinicians´ greatest wish is to extend the latter while improving the former. After neck dissection of early–stage oral carcinoma, “shoulder syndrome” appears due to traction of the accessory nerve during removal of level Ⅱb, which greatly affects patient quality of life. Since occult metastasis in level Ⅱb of early–stage oral carcinoma is extremely low, some surgeons suggest that level Ⅱb can be exempt from dissection to improve HRQoL. However, other surgeons take the opposite view, and thus there is no consensus on the necessity of Ⅱb dissection in T1–2N0M0 oral squamous¬ cell carcinoma (OSCC). Methods: We designed a parallel–group, randomized, non–inferiority trial that is supported by Shanghai Ninth People´s Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China. We will enroll 522 patients of early oral carcinoma who match the inclusion criteria, and compare differences in 3–year overall survival, progression–free survival (PFS) and in HRQoL under different interventions (retention or dissection of level Ⅱb) between two groups. The primary end points will be tested by means of two-sided log-rank tests. Analysis of overall and progression–free survival will be performed in subgroups that were defined according to stratification factors with the use of univariate Cox analysis. In addition, we will use post hoc subgroup analyses on the basis of histological factors that were known to have effects on survival, such as death of invasion of the primary tumor. To evaluate HRQoL, we will choose the Constant–Murley scale to measure shoulder function. Discussion: Currently, there are no RCTs with large sample sizes on the necessity of IIb dissection in T1–T2N0M0 OSCC. We designed this reasonable non–inferiority RCT that combines survival rate and HRQoL to assess the feasibility of IIb neck dissection. The result of this trial may guide clinical practice and change the criteria of how early–stage oral cancer is managed. The balance between survival and HRQoL in this trial is based on early-stage breast cancer treatment and may provide new ideas for other malignancies.


ORL ◽  
2021 ◽  
Vol 83 (5) ◽  
pp. 341-346
Author(s):  
Ozan Muzaffer Altuntaş ◽  
Furkan Özer ◽  
Oğuz Kuşçu ◽  
Nilda Süslü

<b><i>Purpose:</i></b> Our study aimed to quantify the impact of submandibular gland (SMG) resection during Level I neck dissection (ND) on stimulated salivary output (SSO) and xerostomia-related quality of life in patients with head and neck cancer (HNC). <b><i>Methods:</i></b> A retrospective cohort was formed from 32 patients that underwent unilateral or bilateral Level I ND and a control group of 23 patients that had level II–IV ND. SSO (Saxon test) and University of Washington Quality of Life survey results for both groups were compared. <b><i>Results:</i></b> Mean SSO was 3.41 g in the SMG resection group and 3.86 g in the control group, with no significant statistical difference. There was no difference in mean SSO between patients with 2 SMGs, a single remaining SMG, or no glands. The mean SSO of SMG resection cases with a history of adjuvant RT was 2.61 g which was below the xerostomia threshold for the Saxon test (2.75 g) and control group patients with RT had a significantly higher mean SSO (4.07 g). The lowest UW-QoL saliva domain score average (53.8) was in the SMG-resected, RT-positive group. <b><i>Conclusion:</i></b> Results indicate unilateral or bilateral resection of SMG does not reduce SSO to a significant extent. Adjuvant radiotherapy and SMG resection are additive risk factors for xerostomia and the related loss in quality of life. SMG sparing may be necessary in HNC patients with higher risk for the need of adjuvant radiation.


Sign in / Sign up

Export Citation Format

Share Document